The Effect and Safety of Pulsed Field Ablation (PFA) in Patients With Paroxysmal Atrial Fibrillation (PAF)

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 144 participants.

Also called NCT05400928

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 144 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05400928
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05400928. Allocation not applicable; no masking; primary purpose treatment. Start 2021-07-05 (actual); primary completion 2022-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effect and Safety of Pulsed Field Ablation (PFA) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Acronym
ESPFA-CN21
Condition
Paroxysmal Atrial Fibrillation
Intervention (Device)
Pulsed Field Ablation
Lead sponsor
Tongji Hospital (class: other)
Collaborator
Jiangxi Provincial People's Hopital (class: other)
Collaborator
Second Affiliated Hospital of Guangzhou Medical University (class: other)
Collaborator
Central South University (class: other)
Collaborator
Second Affiliated Hospital of Nanchang University (class: other)
Collaborator
Zhongshan Hospital Xiamen University (class: other)
Collaborator
The First Affiliated Hospital of Dalian Medical University (class: other)
Collaborator
Chinese Academy of Medical Sciences, Fuwai Hospital (class: other)

Record details

Record id
cardio:ct-nct05400928
Content hash
0a987ad476620903ef7d66379bc46e1d4a2cf02a22a4f7d501af4fbd221290e0